NCT00384332View on ClinicalTrials.gov

Medication, Weight Gain and GI Hormones

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Bipolar Depression
Interventions
DRUG

orally-disintegrating olanzapine

5 to 20 mg (daily) orally disintegrating olanzapine for approx.8 weeks.

DRUG

regular olanzapine

5-20 mg. olanzapine daily for approximately 8 weeks.

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Vanderbilt University

OTHER

NCT00384332 - Medication, Weight Gain and GI Hormones | Biotech Hunter | Biotech Hunter